# A Study on the Improvement of Postoperative Symptoms and Survival Benefits of Modified Bufei Decoction in Elderly Patients With Lung Cancer Undergoing Radical Surgery

> **NCT06674252** · NA · RECRUITING · sponsor: **Peking University Cancer Hospital & Institute** · enrollment: 174 (estimated)

## Conditions studied

- Lung Cancers

## Interventions

- **OTHER:** Jiawei Bufei Tang granules
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06674252
- **Lead sponsor:** Peking University Cancer Hospital & Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-06-13
- **Primary completion:** 2027-09
- **Final completion:** 2027-12
- **Target enrollment:** 174 (ESTIMATED)
- **Last updated:** 2026-01-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06674252

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06674252, "A Study on the Improvement of Postoperative Symptoms and Survival Benefits of Modified Bufei Decoction in Elderly Patients With Lung Cancer Undergoing Radical Surgery". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06674252. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*